Omeros Analyst Price Targets - Benzinga

Omeros Corp

OMERNASDAQ

Trade with Public

Trade with Public

$16.11

-2.68-14.26%

最終更新: Oct 16, 3:55 PM

$17.90

-0.89-4.74%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

© 2026 Benzinga | All Rights Reserved

Omeros Analyst Price Targets - Benzinga

Omeros Analyst Price Targets

Wall Street analyst price targets and consensus rating for Omeros (OMER).

Price Target Range — 9 Quarters

Analyst Consensus — 6 Analysts

1S.Buy

4Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$26Upside to Avg. PT+59.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	Cantor Fitzgerald	Olivia Brayer Saunders	Maintained	Overweight	$22
Sep 22, 2026	Cantor Fitzgerald	Olivia Brayer Saunders	Upgrade	Neutral→Overweight	$22
Jun 26, 2026	HC Wainwright & Co.	Brandon Folkes	PT Cut	Buy	$40→$33
Jun 10, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$40
May 14, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$40
Apr 21, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Jan 27, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Jan 8, 2026	HC Wainwright & Co.	Brandon Folkes	PT Raise	Buy	$20→$40
Jan 8, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Dec 24, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Dec 1, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Nov 14, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Oct 16, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Oct 15, 2025	Needham	Serge Belanger	Maintained	Hold	—
Oct 15, 2025	WBB Securities	Steve Brozak	Maintained	Strong Buy	$45
Oct 15, 2025	HC Wainwright & Co.	Brandon Folkes	PT Raise	Buy	$9→$20
Oct 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Sep 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Aug 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Aug 15, 2025	Needham	Serge Belanger	Maintained	Hold	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Cantor Fitzgerald Reiterates Overweight on Omeros, Maintains $22 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates Omeros (NASDAQ:OMER) with a Overweight and maintains $22 price target.

Benzinga Newsdesk

This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday

Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.

Avi Kapoor

Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst

Cantor upgrades Omeros to Overweight with a $22 price forecast following strong Yartemlea sales and Medicare reimbursement momentum.

Vandana Singh

PRO
Cantor Fitzgerald Upgrades Omeros to Overweight, Announces $22 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders upgrades Omeros (NASDAQ:OMER) from Neutral to Overweight and announces $22 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Omeros, Lowers Price Target to $33

HC Wainwright & Co. analyst Brandon Folkes maintains Omeros (NASDAQ:OMER) with a Buy and lowers the price target from $40 to $33.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Omeros, Maintains $40 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Omeros (NASDAQ:OMER) with a Buy and maintains $40 price target.

Benzinga Newsdesk